Onxeo to Present Data supporting Lead Asset AsiDNA in 5 Poster Presentations at 2019 American Association for Cancer Research Annual Meeting

14:04 EDT 25 Mar 2019 | FinanzNachrichten

Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), ("Onxeo" or "the Company"), a clinical-stage biotechnology company specializing in the development of innovative drugs targe...

More From BioPortfolio on "Onxeo to Present Data supporting Lead Asset AsiDNA in 5 Poster Presentations at 2019 American Association for Cancer Research Annual Meeting"